NRX Pharmaceuticals, Inc.
NRXPDrugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Aug 17, 2026
13dMarket Overview
Stock performance and key metrics
2 upcoming, 0 past
FDA PDUFA Date NRX-101 (standard)
For bipolar depression and suicidal ideation. NDA filing. Extracted from SEC filing: 8-K
SourceNRXP Earnings Report
EPS Est: $-0.09 | FQ end 2026-06
How NRXP's past catalysts played out
No drugs found in this phase.
Full breakdown — the signals behind the verdict
Frequently asked questions
When is NRX Pharmaceuticals, Inc.'s next FDA catalyst?→
NRX Pharmaceuticals, Inc.'s (NRXP) next tracked catalyst is a Earnings expected August 17, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track NRXP biotech catalysts?→
Add NRXP to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow NRX Pharmaceuticals, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.